Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:1.4.1.2 (glutamate dehydrogenase)
 4,380 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Two or three different kinds of immobilized enzymes can be aligned in a minireactor so that sequential enzymatic reactions are carried out from upstream to downstream during flow-injection analysis. A lactate oxidase-catalase reactor, used as precolumn for removing pre-existing lactate in serum before the lactose dehydrogenase (LDH) reactions, was useful for the determination of serum LDH activity, which did not require any blank correction. A sequential glutamate dehydrogenase-glutamate oxidase reactor was also useful for a novel chemiluminometric determination of ammonia. On the other hand, a co-immobilized creatininase-creatinase-sarcosine oxidase reactor, in spite of containing creatininase which catalyses the reversible reaction, was the most efficient for the determination of serum creatinine.
 ...
PMID:Use of various types of column reactors for flow-injection analysis. 151 46

An enzymatic semi-solid surface fluorometric method is described for the determination of serum creatinine on silicone-rubber pads. In this method, the glutamate dehydrogenase, alpha-ketoglutarate, ADP and NADH are mixed, then 30 microliters of diluted serum is added. After the free ammonium ion in serum is consumed, creatininase is added to initiate the assay. The rate of disappearance of NADH fluorescence at 460 nm (excitation wavelength 340 nm) is monitored and is proportional to the serum creatinine concentration. The whole assay uses only 0.41 I.U. creatininase, and takes less than 5 min. The calibration curve is linear up to 82 mg creatinine per liter. The proposed method offers a rapid, simple and inexpensive means for creatinine assay. The results obtained correlate well with the modified Jaffe method applied on Technicon SMA 12/60, with a correlation coefficient of 0.998. The recovery averages 99.3%.
 ...
PMID:Fluorometric enzymatic determination of serum creatinine on the surface of silicone-rubber pads. 735 Oct 75

A two-step method for assaying creatinine in serum and urine samples, suitable with automated analyzers, is reported. Reagent 1, for the first step, contains a blanking system [creatine amidinohydrolase (CRTase), urease, glutamate dehydrogenase, NADPH, and 2-oxoglutarate] and a NADPH-regenerating system [Mg(2+)-dependent isocitrate dehydrogenase (ICD), MgCl2, and excess isocitrate]. Reagent 2, for the second step, contains the metal-chelating reagent trans-1,2-cyclohexanediamine-N,N,N',N'-tetraacetic acid (CyDTA) and a trigger system [creatinine amidohydrolase (CRNase)]. When a specimen is mixed with reagent 1, all the creatine, urea, and NH3 present are removed by the blanking and NADPH systems. On adding reagent 2, CyDTA inactivates ICD to inhibit the NADPH system. Simultaneously, the creatinine (1 mol) in the specimen is hydrolyzed into creatine by CRNase, and then releases NADP+ (2 mol) through the blanking system. Our optimized method can determine creatinine linearly up to 500 mg/L, with within-day CVs < 1.2% and day-to-day CVs < 2.7%.
 ...
PMID:Enzymatic rate assay of creatinine in serum and urine. 840 98